{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:10:53Z","timestamp":1792141853259,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Unlike in adult rheumatology, for most forms of juvenile idiopathic arthritis (JIA) no reliable biomarkers currently exist to assess joint and disease activity. However, electrophoresis is frequently found changed in active juvenile arthritis. The objective of this study was to evaluate the \u03b12-fraction of serum electrophoresis and its main components as biomarkers for JIA, categories extended\/persistent oligoarthritis and seronegative polyarthritis, in comparison with the conventionally used erythrocyte sedimentation rate and C-reactive protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Serum samples and clinical data from 181 patients with JIA were collected. Serum electrophoresis and \u03b12-fraction and its components were determined using standard methods. Relationship between calculated \u03b12-fraction of serum electrophoresis (CA2F) and its components, acute-phase parameters and cJADAS27 was assessed using Pearson\u2019s correlation coefficient and linear regression modelling, adjusting for confounding effects. Results were confirmed in a second cohort with 223 serum samples from 37 patients, using a mixed model to account for repeated measures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to ESR and CRP, CA2F showed higher correlation to cJADAS27, in particular for persistent oligoarthritis. Of the three components of the \u03b12-fraction, haptoglobin showed the highest correlation to cJADAS27. Regression analysis demonstrated higher ability to predict cJADAS27 for CA2F, and especially for haptoglobin as a component thereof, than for CRP and ESR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Compared to conventional methods, \u03b12-fraction of serum electrophoresis and specifically, haptoglobin show higher correlations with disease activity in common subtypes of JIA, representing excellent candidates as biomarkers for disease activity. Further studies are necessary to determine diagnostic value and correlations in other subtypes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-022-00721-7","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T07:15:54Z","timestamp":1660374954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["\u03b12-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Ludwig","family":"Zeller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal N.","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1145-6719","authenticated-orcid":false,"given":"Boris","family":"H\u00fcgle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"721_CR1","first-page":"1520","volume":"29","author":"PJ Manners","year":"2002","unstructured":"Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much? J Rheumatol. 2002;29:1520\u201330.","journal-title":"J Rheumatol"},{"key":"721_CR2","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390\u20132.","journal-title":"J Rheumatol"},{"key":"721_CR3","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","volume":"294","author":"PJ Hashkes","year":"2005","unstructured":"Hashkes PJ, Laxer RM. Medical treatment of juvenile idiopathic arthritis. JAMA. 2005;294:1671\u201384.","journal-title":"JAMA"},{"key":"721_CR4","first-page":"209","volume-title":"Juvenile Idiopathic Arthritis: Classification and Basic Concepts. Textbook of Pediatric Rheumatology","author":"RE Petty","year":"2020","unstructured":"Petty RE, Laxer RM, Wedderburn LR. Juvenile Idiopathic Arthritis: Classification and Basic Concepts. Textbook of Pediatric Rheumatology. 8th ed. Philadelphia: Elsevier, Inc; 2020. p. 209\u201315.","edition":"8"},{"key":"721_CR5","unstructured":"Yildirim K, Karatay S Fau - Melikoglu MA, Melikoglu Ma Fau - Gureser G, Gureser G Fau - Ugur M, Ugur M Fau - Senel K, Senel K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci. 2004;34:423\u20136."},{"key":"721_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/acr.22665","volume":"68","author":"PF Weiss","year":"2016","unstructured":"Weiss PF, Xiao R, Biko DM, Chauvin NA. Assessment of Sacroiliitis at Diagnosis of Juvenile Spondyloarthritis by Radiography, Magnetic Resonance Imaging, and Clinical Examination. Arthritis Care Res (Hoboken). 2016;68:187\u201394.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"721_CR7","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1002\/art.24137","volume":"58","author":"H Wittkowski","year":"2008","unstructured":"Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J, et al. S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin. Arthritis Rheum. 2008;58:3924\u201331.","journal-title":"Arthritis Rheum"},{"key":"721_CR8","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","volume":"72","author":"F McErlane","year":"2013","unstructured":"McErlane F, Beresford MW, Baildam EM, Chieng SE, Davidson JE, Foster HE, et al. Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis. Ann Rheum Dis. 2013;72:1983\u20138.","journal-title":"Ann Rheum Dis"},{"key":"721_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2017-212104","volume":"77","author":"JF Swart","year":"2018","unstructured":"Swart JF, van Dijkhuizen EHP, Wulffraat NM, de Roock S. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann Rheum Dis. 2018;77:336\u201342.","journal-title":"Ann Rheum Dis"},{"key":"721_CR10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/rheumatology\/ket150","volume":"52","author":"F McErlane","year":"2013","unstructured":"McErlane F, Beresford MW, Baildam EM, Thomson W, Hyrich KL. Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis. Rheumatology (Oxford). 2013;52:1941\u201351.","journal-title":"Rheumatology (Oxford)"},{"key":"721_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1089\/ars.2016.6793","volume":"26","author":"CBF Andersen","year":"2017","unstructured":"Andersen CBF, Stodkilde K, Saederup KL, Kuhlee A, Raunser S, Graversen JH, et al. Haptoglobin. Antioxid Redox Signal. 2017;26:814\u201331.","journal-title":"Antioxid Redox Signal"},{"key":"721_CR12","volume-title":"Labor und Diagnose: Indikation und Bewertung von Laborbefunden f\u00fcr die medizinische Diagnostik","author":"L Thomas","year":"2012","unstructured":"Thomas L. Labor und Diagnose: Indikation und Bewertung von Laborbefunden f\u00fcr die medizinische Diagnostik. 8th ed. Frankfurt am Main: TH-Books; 2012.","edition":"8"},{"key":"721_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum. 2009;61:658\u201366.","journal-title":"Arthritis Rheum"},{"key":"721_CR14","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/acr.22393","volume":"66","author":"A Consolaro","year":"2014","unstructured":"Consolaro A, Negro G, Chiara Gallo M, Bracciolini G, Ferrari C, Schiappapietra B, et al. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Arthritis Care Res (Hoboken). 2014;66:1703\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"721_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/bimj.200710415","volume":"50","author":"MD Ruopp","year":"2008","unstructured":"Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50:419\u201330.","journal-title":"Biom J"},{"key":"721_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","volume":"51","author":"JE Pope","year":"2021","unstructured":"Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum. 2021;51:219\u201329.","journal-title":"Semin Arthritis Rheum"},{"key":"721_CR17","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/1529-0131(200105)44:5<995::AID-ANR177>3.0.CO;2-L","volume":"44","author":"JP Atkinson","year":"2001","unstructured":"Atkinson JP. C-reactive protein: a rheumatologist\u2019s friend revisited. Arthritis Rheum. 2001;44:995\u20136.","journal-title":"Arthritis Rheum"},{"key":"721_CR18","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68:954\u201360.","journal-title":"Ann Rheum Dis"},{"key":"721_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369:767\u201378.","journal-title":"Lancet"},{"key":"721_CR20","first-page":"241","volume-title":"Oligoarticular Juvenile Idiopathic Arthritis. Textbook of Pediatric Rheumatology","author":"S Ringold","year":"2020","unstructured":"Ringold S, Horneff G. Oligoarticular Juvenile Idiopathic Arthritis. Textbook of Pediatric Rheumatology. 8th ed. Philadelphia: Elsevier, Inc; 2020. p. 241\u20139.","edition":"8"},{"key":"721_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/ard.41.3.259","volume":"41","author":"M Gwyther","year":"1982","unstructured":"Gwyther M, Schwarz H, Howard A, Ansell BM. C-reactive protein in juvenile chronic arthritis: an indicator of disease activity and possibly amyloidosis. Ann Rheum Dis. 1982;41:259\u201362.","journal-title":"Ann Rheum Dis"},{"key":"721_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00296-017-3657-x","volume":"37","author":"M Alberdi-Saugstrup","year":"2017","unstructured":"Alberdi-Saugstrup M, Zak M, Nielsen S, Herlin T, Nordal E, Berntson L, et al. High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis. Rheumatol Int. 2017;37:695\u2013703.","journal-title":"Rheumatol Int"},{"key":"721_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12098-017-2292-6","volume":"84","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Alam MM, Das G, Datta S. Inflammatory Markers and Disease Activity in Juvenile Idiopathic Arthritis. Indian J Pediatr. 2017;84:349\u201356.","journal-title":"Indian J Pediatr"},{"key":"721_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/ard.56.3.197","volume":"56","author":"A Ravelli","year":"1997","unstructured":"Ravelli A, Viola S, Ruperto N, Corsi B, Ballardini G, Martini A. Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis. 1997;56:197\u2013200.","journal-title":"Ann Rheum Dis"},{"key":"721_CR25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1136\/annrheumdis-2011-200237","volume":"71","author":"EB Nordal","year":"2012","unstructured":"Nordal EB, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, et al. Validity and predictive ability of the juvenile arthritis disease activity score based on CRP versus ESR in a Nordic population-based setting. Ann Rheum Dis. 2012;71:1122\u20137.","journal-title":"Ann Rheum Dis"},{"key":"721_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clinbiochem.2017.09.017","volume":"51","author":"A Regeniter","year":"2018","unstructured":"Regeniter A, Siede WH. Peaks and tails: Evaluation of irregularities in capillary serum protein electrophoresis. Clin Biochem. 2018;51:48\u201355.","journal-title":"Clin Biochem"},{"key":"721_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000212077","volume":"79","author":"SR Vavricka","year":"2009","unstructured":"Vavricka SR, Burri E, Beglinger C, Degen L, Manz M. Serum protein electrophoresis: an underused but very useful test. Digestion. 2009;79:203\u201310.","journal-title":"Digestion"},{"key":"721_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/ard.33.1.35","volume":"33","author":"KM Goel","year":"1974","unstructured":"Goel KM, Logan RW, Barnard WP, Shanks RA. Serum immunoglobulin and beta 1C-beta 1A globulin concentrations in juvenile rheumatoid arthritis. Ann Rheum Dis. 1974;33:35\u20138.","journal-title":"Ann Rheum Dis"},{"key":"721_CR29","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/j.1460-2075.1989.tb03485.x","volume":"8","author":"S Oliviero","year":"1989","unstructured":"Oliviero S, Cortese R. The human haptoglobin gene promoter: interleukin-6-responsive elements interact with a DNA-binding protein induced by interleukin-6. EMBO J. 1989;8:1145\u201351.","journal-title":"EMBO J"},{"key":"721_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0006-291X(91)91820-3","volume":"178","author":"N Frohlander","year":"1991","unstructured":"Frohlander N, Ljunggren O, Lerner UH. Haptoglobin synergistically potentiates bradykinin and thrombin induced prostaglandin biosynthesis in isolated osteoblasts. Biochem Biophys Res Commun. 1991;178:343\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"721_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2006.04.032","volume":"191","author":"J Guetta","year":"2007","unstructured":"Guetta J, Strauss M, Levy NS, Fahoum L, Levy AP. Haptoglobin genotype modulates the balance of Th1\/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis. 2007;191:48\u201353.","journal-title":"Atherosclerosis"},{"key":"721_CR32","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/192558a0","volume":"192","author":"OW Neuhaus","year":"1961","unstructured":"Neuhaus OW, Sogoian VP. Presence of haptoglobin in synovial fluid. Nature. 1961;192:558\u20139.","journal-title":"Nature"},{"key":"721_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/03009748409102666","volume":"13","author":"JS Dixon","year":"1984","unstructured":"Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V. C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol. 1984;13:39\u201344.","journal-title":"Scand J Rheumatol"},{"key":"721_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3109\/rhe1.1965.11.issue-1-4.02","volume":"11","author":"E Nettelblat","year":"1965","unstructured":"Nettelblat E, Sundblad L. Haptoglobins in Serum and Synovial Fluid. Acta Rheumatol Scand. 1965;11:11\u20134.","journal-title":"Acta Rheumatol Scand"},{"key":"721_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2613.2003.00336.x","volume":"84","author":"MB Smeets","year":"2003","unstructured":"Smeets MB, Fontijn J, Kavelaars A, Pasterkamp G, De Kleijn DP. The acute phase protein haptoglobin is locally expressed in arthritic and oncological tissues. Int J Exp Pathol. 2003;84:69\u201374.","journal-title":"Int J Exp Pathol"},{"key":"721_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1189\/jlb.0208100","volume":"84","author":"KM Huntoon","year":"2008","unstructured":"Huntoon KM, Wang Y, Eppolito CA, Barbour KW, Berger FG, Shrikant PA, et al. The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol. 2008;84:170\u201381.","journal-title":"J Leukoc Biol"},{"key":"721_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1182\/blood-2005-09-3890","volume":"108","author":"K Theilgaard-Monch","year":"2006","unstructured":"Theilgaard-Monch K, Jacobsen LC, Nielsen MJ, Rasmussen T, Udby L, Gharib M, et al. Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood. 2006;108:353\u201361.","journal-title":"Blood"},{"key":"721_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13075-015-0553-1","volume":"17","author":"S Blaschke","year":"2015","unstructured":"Blaschke S, Rinke K, Maring M, Flad T, Patschan S, Jahn O, et al. Haptoglobin-alpha1, -alpha2, vitamin D-binding protein and apolipoprotein C-III as predictors of etanercept drug response in rheumatoid arthritis. Arthritis Res Ther. 2015;17:45.","journal-title":"Arthritis Res Ther"},{"key":"721_CR39","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1002\/art.27447","volume":"62","author":"ME Rosenkranz","year":"2010","unstructured":"Rosenkranz ME, Wilson DC, Marinov AD, Decewicz A, Grof-Tisza P, Kirchner D, et al. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis. Arthritis Rheum. 2010;62:1813\u201323.","journal-title":"Arthritis Rheum"},{"key":"721_CR40","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1021\/pr900680w","volume":"8","author":"DS Gibson","year":"2009","unstructured":"Gibson DS, Finnegan S, Jordan G, Scaife C, Brockbank S, Curry J, et al. Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis. J Proteome Res. 2009;8:5601\u20139.","journal-title":"J Proteome Res"},{"key":"721_CR41","first-page":"2359","volume":"21","author":"KL Madson","year":"1994","unstructured":"Madson KL, Moore TL, Lawrence JM 3rd, Osborn TG. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol. 1994;21:2359\u201363.","journal-title":"J Rheumatol"},{"key":"721_CR42","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/0002-9343(85)90224-4","volume":"78","author":"SE Bedell","year":"1985","unstructured":"Bedell SE, Bush BT. Erythrocyte sedimentation rate. From folklore to facts. Am J Med. 1985;78:1001\u20139.","journal-title":"Am J Med"},{"key":"721_CR43","first-page":"421","volume":"23","author":"S Magni-Manzoni","year":"2005","unstructured":"Magni-Manzoni S, Cugno C, Pistorio A, Garay S, Tsitsami E, Gasparini C, et al. Responsiveness of clinical measures to flare of disease activity in juvenile idiopathic arthritis. Clin Exp Rheumatol. 2005;23:421\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"721_CR44","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jprot.2016.11.012","volume":"152","author":"P Fern\u00e1ndez-Puente","year":"2017","unstructured":"Fern\u00e1ndez-Puente P, Calamia V, Gonz\u00e1lez-Rodr\u00edguez L, Lourido L, Camacho-Encina M, Oreiro N, et al. Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis. J Proteomics. 2017;152:216\u201325.","journal-title":"J Proteomics"},{"key":"721_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12891-015-0730-z","volume":"16","author":"R Liu","year":"2015","unstructured":"Liu R, Fan L, Yin L, Wang K, Miao W, Song Q, et al. Comparative study of serum proteomes in Legg-Calve-Perthes disease. BMC Musculoskelet Disord. 2015;16:281.","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00721-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00721-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T08:06:07Z","timestamp":1660377967000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00721-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["721"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00721-7","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Medical Faculty, Ludwig-Maximilians University Munich, Germany (Nr. 11073).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}